Form EFFECT Artiva Biotherapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | August 14, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Port of Subs® Launches New Chicken Cordon Bleu, Seasonal Menu and Back-to-School Rewards
- West Point Gold Buys Back 2% Royalty, Secures 100% Ownership of Black Dyke and Bull 8 Discoveries
- Alaska Silver Announces Closing of C$7.6 Million Pipe Financing
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
